New Haven, Connecticut — New Haven, Connecticut

New Haven, Connecticut is a clinical research site located in New Haven, Connecticut, United States 06519-1109.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

New Haven, Connecticut has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia, Alopecia Areata, Apathy in Dementia.

Sponsors: AbbVie, Q32 Bio Inc., Cerevel Therapeutics, LLC.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Haven, Connecticut?

New Haven, Connecticut has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Haven, Connecticut conducted?

New Haven, Connecticut has 7 clinical trials on record, with 1 currently active. Their work covers Schizophrenia, Alopecia Areata, Apathy in Dementia.

Is New Haven, Connecticut accredited by Crixeo Health?

New Haven, Connecticut has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Haven, Connecticut?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.